STOCK TITAN

Archimedes Tech SPAC Partners III Co. (ARCI) 10-Q Filings

ARCI NASDAQ

Here are the 10-Q quarterly reports from Archimedes Tech SPAC Partners III Co. (ARCI) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow ARCI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ARCI filings page.

Rhea-AI Summary

Archimedes Tech SPAC Partners III Co. (ARCI) reported net income of $2,335,083 for the three months ended September 30, 2026, including $2,563,380 of Trust Account interest, offset by $237,214 in general and administrative expenses. Nine-month net income was $6,197,252, including $6,817,505 in Trust Account interest and $647,524 in general and administrative expenses. As of September 30, 2026, the company had not started operations, generated operating revenue or selected a business-combination target.

At quarter-end, the Trust Account held $282,817,505, and cash outside it was $860,213. The trust included 27,600,000 public shares subject to possible redemption at approximately $10.25 per share. The stated business-combination window is 24 months from the IPO closing, subject to an earlier board-approved liquidation date or a different period established by amendment. Public shareholders may redeem at combination closing; the $9,660,000 deferred underwriting fee is payable from trust funds only if a combination is completed. Management believes available funds can cover operating needs for one year, though higher-than-estimated search and transaction costs could leave insufficient funds. Management concluded disclosure controls were effective at a reasonable assurance level.

Rhea-AI Summary

Archimedes Tech SPAC Partners III Co., a Cayman Islands blank check company focused on technology targets, completed its IPO on January 26, 2026, selling 27,600,000 units at $10.00 each for gross proceeds of $276,000,000. As of June 30, 2026, total assets were $281,499,401, including $280,254,125 held in a Trust Account for public shareholders and $1,009,308 in cash outside the trust.

For the six months ended June 30, 2026, the company reported net income of $3,862,169, driven by $4,254,125 of interest on Trust Account deposits, partially offset by $410,310 of general and administrative expenses. Ordinary shares subject to possible redemption totaled 27,600,000 at a redemption value of $10.15 per share, recorded as temporary equity.

The SPAC has a 24‑month Completion Window from the IPO closing to complete an initial business combination. As of June 30, 2026, working capital was $1,053,342, no Working Capital Loans were outstanding, and management concluded existing resources are sufficient to fund operations for at least one year. Deferred underwriting fees of $9,660,000 are payable only upon a successful business combination.

Rhea-AI Summary

Archimedes Tech SPAC Partners III Co. reported net income of $1,574,054 for the three months ended March 31, 2026, driven mainly by interest on IPO proceeds held in trust.

The SPAC completed its January 2026 IPO of 27,600,000 units at $10.00, placing $276,000,000 into a U.S. Treasury-backed Trust Account, which totaled $277,775,824 with interest as of March 31. Cash outside the trust was $1,109,625, with working capital of about $1.2 million to fund search and operating costs.

Total assets were $279.2 million, largely redeemable ordinary shares recorded at $10.06 per share, creating a shareholders’ deficit as is typical for SPACs. The company has up to 24 months from the IPO closing to complete a business combination and had no off-balance sheet arrangements or working capital loans outstanding.